Cited by 110Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and HealthCardiovascular Health and Risk Factors

Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis

Open access
Zhang, Xuanping, Devlin, Heather M., Smith, Bryce, Imperatore, Giuseppina, Thomas, William, Lobelo, Felipe, Ali, Mohammed K., Norris, Keri +10 more·2017·PLOS ONE

Abstract

Structured lifestyle interventions can reduce diabetes incidence and cardiovascular disease (CVD) risk among persons with impaired glucose tolerance (IGT), but it is unclear whether they should be implemented among persons without IGT. We conducted a systematic review and meta-analyses to assess the effectiveness of lifestyle interventions on CVD risk among adults without IGT or diabetes. We systematically searched MEDLINE, EMBASE, CINAHL, Web of Science, the Cochrane Library, and PsychInfo databases, from inception to May 4, 2016. We selected randomized controlled trials of lifestyle interventions, involving physical activity (PA), dietary (D), or combined strategies (PA+D) with follow-up duration ≥12 months. We excluded all studies that included individuals with IGT, confirmed by 2-hours oral glucose tolerance test (75g), but included all other studies recruiting populations with different glycemic levels. We stratified studies by baseline glycemic levels: (1) low-range group with mean fasting plasma glucose (FPG) <5.5mmol/L or glycated hemoglobin (A1C) <5.5%, and (2) high-range group with FPG ≥5.5mmol/L or A1C ≥5.5%, and synthesized data using random-effects models. Primary outcomes in this review included systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Totally 79 studies met inclusion criteria. Compared to usual care (UC), lifestyle interventions achieved significant improvements in SBP (-2.16mmHg[95%CI, -2.93, -1.39]), DBP (-1.83mmHg[-2.34, -1.31]), TC (-0.10mmol/L[-0.15, -0.05]), LDL-C (-0.09mmol/L[-0.13, -0.04]), HDL-C (0.03mmol/L[0.01, 0.04]), and TG (-0.08mmol/L[-0.14, -0.03]). Similar effects were observed among both low-and high-range study groups except for TC and TG. Similar effects also appeared in SBP and DBP categories regardless of follow-up duration. PA+D interventions had larger improvement effects on CVD risk factors than PA alone interventions. In adults without IGT or diabetes, lifestyle interventions resulted in significant improvements in SBP, DBP, TC, LDL-C, HDL-C, and TG, and might further reduce CVD risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0176436

Cites

146 of 146 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An increased animal fat (saturated fatty acid [SFA]) intake has been shown to be associated with the risk of diabetes.

    “an increased animal fat (saturated fatty acid [SFA]) intake has been shown to be associated with the risk of diabetes 19 , 20 , 21 , 22 , 23 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [21]

  • DPP-4 inhibitors are not associated with an increased risk of macroangiopathy.

    “They are not associated with an increased risk of macroangiopathy 21 , 22 , 23 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [21]

  • DPP-4 inhibitors appear to have a favorable safety profile.

    “Thus, at present, DPP‐4 inhibitors appear to have a favorable safety profile 19 , 20 , 21 , 22 , while attention needs to be given to the potential onset of acute pancreatitis and bullous pemphigoid with these agents.”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [21]

  • Protein restriction is likely effective in inhibiting the progression of diabetic nephropathy in patients with overt or more advanced nephropathy.

    “While protein restriction is thought likely to be effective in inhibiting the progression of diabetic nephropathy in patients with overt or more advanced nephropathy, there is a paucity of clinical evidence to support its implementation 21 , 22 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [21]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 147 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zhang, X., Devlin, H. M., Smith, B., Imperatore, G., Thomas, W., Lobelo, F., Ali, M. K., Norris, K., Gruss, S., Bardenheier, B., Cho, P., Garcia de Quevedo, I., Mudaliar, U., Jones, C. D., Durthaler, J. M., Saaddine, J., Geiss, L. S., & Gregg, E. W.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Emory University (US)
Corresponding author
Zhang, Xuanping
Venue
PLOS ONE
Published
2017-05-11
Volume
12
Issue
5
Pages
e0176436
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2613978613
Cited by
110
References
147
Citations by year
2026: 6 · 2025: 2 · 2024: 10 · 2023: 16 · 2022: 20 · 2021: 16 · 2020: 18 · 2019: 8 · 2018: 12 · 2017: 2
FWCI
1.59
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Spiral (Imperial College London) (submittedVersion, public-domain)
Funders
Centers for Disease Control and Prevention
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
lifestyle intervention, cardiovascular risk factors, physical activity, dietary intervention, blood pressure, lipid profile, impaired glucose tolerance, prediabetes, glycemic status, cardiovascular disease prevention, adults without diabetes, usual care comparison, triglycerides, HDL cholesterol, LDL cholesterol, total cholesterol, systolic and diastolic blood pressure, follow-up duration
MeSH terms
Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Glycated Hemoglobin, Humans, Life Style, Cholesterol, HDL, Cholesterol, LDL, Risk Factors, Triglycerides, Exercise, Randomized Controlled Trials as Topic, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review